Weight Loss Medication Calculators
Project your expected weight loss on GLP-1 medications like Ozempic, Mounjaro, Wegovy, and Zepbound. All projections based on published clinical trial data from STEP and SURMOUNT studies.
11 free toolsUnderstanding GLP-1 Weight Loss Projections
GLP-1 receptor agonists represent a breakthrough in obesity treatment, with clinical trials showing 15-25% total body weight loss depending on the medication and dose. Our calculators model these outcomes using data from the largest published trials.
How These Calculators Work
Each calculator uses a logarithmic weight loss curve fitted to trial-reported outcomes at specific time points. This captures the real pattern of GLP-1 weight loss: rapid initial loss that gradually plateaus over 12-18 months. Your projection accounts for starting weight, dose, and treatment duration.
Key Differences Between Medications
- Ozempic (semaglutide 1mg) — Originally approved for type 2 diabetes. Average weight loss ~12-15% over 68 weeks in STEP trials
- Wegovy (semaglutide 2.4mg) — Higher-dose semaglutide specifically for obesity. ~15-17% weight loss in STEP trials
- Mounjaro/Zepbound (tirzepatide) — Dual GIP/GLP-1 agonist. ~20-25% weight loss in SURMOUNT trials, the most effective option to date
Important Caveats
Individual results vary significantly from trial averages. Factors like diet, exercise, starting BMI, and genetics all influence outcomes. These projections are estimates based on population-level data, not guarantees. Always work with your prescribing physician to set realistic expectations.